Walgreens Boots Alliance, Inc. (0LSZ.L)
USD 10.85
(0.09%)
USD 10.85
(0.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -14.07 Billion USD | -104.53% |
| 2023 | -6.88 Billion USD | -596.18% |
| 2022 | 1.38 Billion USD | -40.78% |
| 2021 | 2.34 Billion USD | 138.49% |
| 2020 | 982 Million USD | -79.4% |
| 2019 | 4.76 Billion USD | -24.22% |
| 2018 | 6.28 Billion USD | 14.68% |
| 2017 | 5.48 Billion USD | -8.62% |
| 2016 | 6 Billion USD | 28.56% |
| 2015 | 4.66 Billion USD | 11.3% |
| 2014 | 4.19 Billion USD | 14.94% |
| 2013 | 3.64 Billion USD | 5.34% |
| 2012 | 3.46 Billion USD | -20.64% |
| 2011 | 4.36 Billion USD | 26.23% |
| 2010 | 3.45 Billion USD | 6.5% |
| 2009 | 3.24 Billion USD | -5.63% |
| 2008 | 3.44 Billion USD | 9.2% |
| 2007 | 3.15 Billion USD | 16.63% |
| 2006 | 2.7 Billion USD | 11.45% |
| 2005 | 2.42 Billion USD | 13.13% |
| 2004 | 2.14 Billion USD | 15.93% |
| 2003 | 1.84 Billion USD | 13.8% |
| 2002 | 1.62 Billion USD | 16.16% |
| 2001 | 1.39 Billion USD | 14.23% |
| 2000 | 1.22 Billion USD | 20.55% |
| 1999 | 1.01 Billion USD | 21.6% |
| 1998 | 835 Million USD | 17.94% |
| 1997 | 708 Million USD | 17.2% |
| 1996 | 604.1 Million USD | 16.15% |
| 1995 | 520.1 Million USD | 14.13% |
| 1994 | 455.7 Million USD | 12.19% |
| 1993 | 406.2 Million USD | 13.31% |
| 1992 | 358.5 Million USD | 11.61% |
| 1991 | 321.2 Million USD | 13.02% |
| 1990 | 284.2 Million USD | 12.11% |
| 1989 | 253.5 Million USD | 13.07% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -13.17 Billion USD | -33671.79% |
| 2024 Q1 | -39 Million USD | 91.35% |
| 2024 Q3 | 111 Million USD | 100.84% |
| 2024 Q4 | -977 Million USD | -980.18% |
| 2023 Q2 | 197 Million USD | 103.2% |
| 2023 Q4 | -451 Million USD | 5.45% |
| 2023 Q1 | -6.15 Billion USD | -648.3% |
| 2023 FY | -6.88 Billion USD | -256.94% |
| 2023 Q3 | -477 Million USD | -342.13% |
| 2022 Q4 | -822 Million USD | -156.88% |
| 2022 Q1 | 1.28 Billion USD | 40.99% |
| 2022 FY | 4.38 Billion USD | 25.97% |
| 2022 Q3 | -320 Million USD | -125.68% |
| 2022 Q2 | 1.24 Billion USD | -2.88% |
| 2021 FY | 3.48 Billion USD | 165.32% |
| 2021 Q1 | -535 Million USD | -187.99% |
| 2021 Q2 | 832 Million USD | 255.51% |
| 2021 Q3 | 1.13 Billion USD | 36.3% |
| 2021 Q4 | 910 Million USD | -19.75% |
| 2020 Q4 | 608 Million USD | 136.13% |
| 2020 FY | 1.31 Billion USD | -73.75% |
| 2020 Q1 | 921 Million USD | 4.9% |
| 2020 Q2 | 1.13 Billion USD | 23.34% |
| 2020 Q3 | -1.68 Billion USD | -248.15% |
| 2019 Q3 | 1.2 Billion USD | -20.7% |
| 2019 FY | 4.99 Billion USD | -22.08% |
| 2019 Q2 | 1.51 Billion USD | 8.36% |
| 2019 Q1 | 1.4 Billion USD | 0.29% |
| 2019 Q4 | 878 Million USD | -27.02% |
| 2018 Q2 | 1.97 Billion USD | 49.89% |
| 2018 FY | 6.41 Billion USD | 15.42% |
| 2018 Q1 | 1.31 Billion USD | 18.4% |
| 2018 Q3 | 1.59 Billion USD | -19.22% |
| 2018 Q4 | 1.39 Billion USD | -12.59% |
| 2017 Q4 | 1.11 Billion USD | -26.57% |
| 2017 Q2 | 1.47 Billion USD | 2.21% |
| 2017 Q1 | 1.44 Billion USD | 26.93% |
| 2017 Q3 | 1.51 Billion USD | 2.57% |
| 2017 FY | 5.55 Billion USD | -7.4% |
| 2016 Q1 | 1.46 Billion USD | 75.6% |
| 2016 Q2 | 1.86 Billion USD | 26.7% |
| 2016 Q4 | 1.14 Billion USD | -25.64% |
| 2016 FY | 6 Billion USD | 28.56% |
| 2016 Q3 | 1.53 Billion USD | -17.58% |
| 2015 FY | 4.66 Billion USD | 11.3% |
| 2015 Q4 | 836 Million USD | -40.33% |
| 2015 Q3 | 1.4 Billion USD | 1.74% |
| 2015 Q2 | 1.37 Billion USD | 30.65% |
| 2015 Q1 | 1.05 Billion USD | 6.9% |
| 2014 FY | 4.19 Billion USD | 6.45% |
| 2014 Q1 | 967 Million USD | 6.15% |
| 2014 Q2 | 1.21 Billion USD | 25.85% |
| 2014 Q4 | 986 Million USD | -3.71% |
| 2014 Q3 | 1.02 Billion USD | -15.86% |
| 2013 FY | 3.94 Billion USD | 13.74% |
| 2013 Q3 | 907 Million USD | -19.23% |
| 2013 Q1 | 727 Million USD | 24.06% |
| 2013 Q2 | 1.12 Billion USD | 54.47% |
| 2013 Q4 | 911 Million USD | 0.44% |
| 2012 Q4 | 586 Million USD | -32.88% |
| 2012 Q1 | 900 Million USD | -28.91% |
| 2012 Q3 | 873 Million USD | -21.0% |
| 2012 Q2 | 1.1 Billion USD | 22.78% |
| 2012 FY | 3.46 Billion USD | -20.64% |
| 2011 Q2 | 1.2 Billion USD | 28.27% |
| 2011 FY | 4.36 Billion USD | 26.23% |
| 2011 Q4 | 1.26 Billion USD | 33.12% |
| 2011 Q3 | 951 Million USD | -21.21% |
| 2011 Q1 | 941 Million USD | 25.8% |
| 2010 Q4 | 748 Million USD | -9.77% |
| 2010 FY | 3.45 Billion USD | 6.5% |
| 2010 Q3 | 829 Million USD | -23.66% |
| 2010 Q2 | 1.08 Billion USD | 36.26% |
| 2010 Q1 | 797 Million USD | 13.53% |
| 2009 Q2 | 1.03 Billion USD | 53.96% |
| 2009 Q3 | 846 Million USD | -17.86% |
| 2009 Q4 | 702 Million USD | -17.02% |
| 2009 FY | 3.24 Billion USD | -5.63% |
| 2009 Q1 | 669 Million USD | -5.89% |
| 2008 Q1 | 727.8 Million USD | 20.6% |
| 2008 FY | 3.44 Billion USD | 9.2% |
| 2008 Q3 | 913.8 Million USD | -16.03% |
| 2008 Q4 | 710.9 Million USD | -22.2% |
| 2008 Q2 | 1.08 Billion USD | 49.52% |
| 2007 Q4 | 603.5 Million USD | -29.4% |
| 2007 Q2 | 1.02 Billion USD | 51.88% |
| 2007 FY | 3.15 Billion USD | 16.63% |
| 2007 Q3 | 854.8 Million USD | -16.24% |
| 2007 Q1 | 671.9 Million USD | 6.45% |
| 2006 Q3 | 707.6 Million USD | -13.8% |
| 2006 FY | 2.7 Billion USD | 11.45% |
| 2006 Q1 | 541.8 Million USD | 3.3% |
| 2006 Q2 | 820.9 Million USD | 51.51% |
| 2006 Q4 | 631.2 Million USD | -10.8% |
| 2005 Q2 | 770.9 Million USD | 54.92% |
| 2005 Q1 | 497.6 Million USD | -3.57% |
| 2005 Q3 | 637.5 Million USD | -17.3% |
| 2005 Q4 | 524.5 Million USD | -17.73% |
| 2005 FY | 2.42 Billion USD | 13.13% |
| 2004 FY | 2.14 Billion USD | 15.93% |
| 2004 Q2 | 677 Million USD | 67.16% |
| 2004 Q3 | 544.7 Million USD | -19.54% |
| 2004 Q4 | 516 Million USD | -5.27% |
| 2004 Q1 | 405 Million USD | -8.31% |
| 2003 Q1 | 352.7 Million USD | -10.64% |
| 2003 Q4 | 441.7 Million USD | -4.12% |
| 2003 Q3 | 460.7 Million USD | -22.34% |
| 2003 Q2 | 593.2 Million USD | 68.19% |
| 2003 FY | 1.84 Billion USD | 13.8% |
| 2002 Q3 | 414.1 Million USD | -20.88% |
| 2002 Q4 | 394.7 Million USD | -4.68% |
| 2002 Q2 | 523.4 Million USD | 79.25% |
| 2002 Q1 | 292 Million USD | -13.69% |
| 2002 FY | 1.62 Billion USD | 16.16% |
| 2001 Q4 | 338.3 Million USD | -2.08% |
| 2001 FY | 1.39 Billion USD | 14.23% |
| 2001 Q3 | 345.5 Million USD | -24.38% |
| 2001 Q2 | 456.9 Million USD | 77.37% |
| 2001 Q1 | 257.6 Million USD | -16.88% |
| 2000 Q4 | 309.9 Million USD | -0.93% |
| 2000 Q2 | 391.2 Million USD | 86.11% |
| 2000 Q3 | 312.8 Million USD | -20.04% |
| 2000 Q1 | 210.2 Million USD | -19.28% |
| 2000 FY | 1.22 Billion USD | 20.55% |
| 1999 Q4 | 260.4 Million USD | 1.6% |
| 1999 Q1 | 170 Million USD | -18.66% |
| 1999 FY | 1.01 Billion USD | 21.6% |
| 1999 Q2 | 330 Million USD | 94.12% |
| 1999 Q3 | 256.3 Million USD | -22.33% |
| 1998 Q4 | 209 Million USD | 2.45% |
| 1998 Q2 | 279 Million USD | 95.1% |
| 1998 Q3 | 204 Million USD | -26.88% |
| 1998 Q1 | 143 Million USD | -16.37% |
| 1998 FY | 835 Million USD | 17.94% |
| 1997 Q2 | 239.5 Million USD | 95.83% |
| 1997 Q4 | 171 Million USD | -2.45% |
| 1997 FY | 708 Million USD | 17.2% |
| 1997 Q1 | 122.3 Million USD | -16.0% |
| 1997 Q3 | 175.3 Million USD | -26.81% |
| 1996 Q3 | 148.3 Million USD | -28.15% |
| 1996 FY | 604.1 Million USD | 16.15% |
| 1996 Q1 | 103.8 Million USD | -15.75% |
| 1996 Q2 | 206.4 Million USD | 98.84% |
| 1996 Q4 | 145.6 Million USD | -1.82% |
| 1995 Q1 | 87.9 Million USD | -21.94% |
| 1995 Q4 | 123.2 Million USD | -3.52% |
| 1995 Q3 | 127.7 Million USD | -29.6% |
| 1995 Q2 | 181.4 Million USD | 106.37% |
| 1995 FY | 520.1 Million USD | 14.13% |
| 1994 FY | 455.7 Million USD | 12.19% |
| 1994 Q1 | 71.4 Million USD | -25.24% |
| 1994 Q4 | 112.6 Million USD | -1.4% |
| 1994 Q3 | 114.2 Million USD | -27.54% |
| 1994 Q2 | 157.6 Million USD | 120.73% |
| 1993 Q3 | 102.8 Million USD | -27.55% |
| 1993 Q4 | 95.5 Million USD | -7.1% |
| 1993 Q2 | 141.9 Million USD | 115.0% |
| 1993 Q1 | 66 Million USD | -20.86% |
| 1993 FY | 406.2 Million USD | 13.31% |
| 1992 Q1 | 58.8 Million USD | -22.02% |
| 1992 Q4 | 83.4 Million USD | -8.75% |
| 1992 FY | 358.5 Million USD | 11.61% |
| 1992 Q2 | 124.9 Million USD | 112.41% |
| 1992 Q3 | 91.4 Million USD | -26.82% |
| 1991 Q4 | 75.4 Million USD | -5.87% |
| 1991 Q1 | 52.9 Million USD | -20.57% |
| 1991 Q2 | 112.7 Million USD | 113.04% |
| 1991 FY | 321.2 Million USD | 13.02% |
| 1991 Q3 | 80.1 Million USD | -28.93% |
| 1990 Q3 | 70.3 Million USD | -29.56% |
| 1990 Q1 | 47.3 Million USD | 101.25% |
| 1990 FY | 284.2 Million USD | 12.11% |
| 1990 Q2 | 99.8 Million USD | 110.99% |
| 1990 Q4 | 66.6 Million USD | -5.26% |
| 1989 FY | 253.5 Million USD | 13.07% |
| 1989 Q4 | -3.78 Billion USD | -380.27% |
| 1989 Q3 | 1.35 Billion USD | -8.53% |
| 1989 Q1 | 1.21 Billion USD | 135.05% |
| 1989 Q2 | 1.47 Billion USD | 21.87% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Thermo Fisher Scientific Inc. | 6.85 Billion USD | 305.219% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -3495.522% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -4999.889% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -11485.662% |
| uniQure N.V. | -282.87 Million USD | -4876.12% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -19052.584% |
| bluebird bio, Inc. | -244.26 Million USD | -5662.665% |
| Imunon, Inc. | -21.03 Million USD | -66831.584% |
| Dynavax Technologies Corporation | -37.02 Million USD | -37914.476% |
| Editas Medicine, Inc. | -169.18 Million USD | -8220.083% |
| Illumina, Inc. | -1.06 Billion USD | -1216.745% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -2956.286% |
| IQVIA Holdings Inc. | 1.97 Billion USD | 811.988% |
| Mettler-Toledo International Inc. | 1.08 Billion USD | 1394.603% |
| Myriad Genetics, Inc. | -123.7 Million USD | -11279.143% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 5710.203% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -5155.69% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -267047.466% |
| Verastem, Inc. | -92.08 Million USD | -15186.043% |
| Waters Corporation | 817.67 Million USD | 1821.464% |
| Biogen Inc. | 1.29 Billion USD | 1185.441% |
| Nektar Therapeutics | -137.42 Million USD | -10142.678% |
| Perrigo Company plc | 151.9 Million USD | 9366.623% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -31126.359% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -12625.218% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -31413.198% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 7339.214% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -5037.133% |
| Evolus, Inc. | -49.23 Million USD | -28490.579% |
| Adicet Bio, Inc. | -152.03 Million USD | -9158.212% |
| Aclaris Therapeutics, Inc. | -97.35 Million USD | -14358.128% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 447.805% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | -8948.424% |
| FibroGen, Inc. | -281.81 Million USD | -4894.766% |
| Agilent Technologies, Inc. | 1.35 Billion USD | 1142.667% |
| OPKO Health, Inc. | -157.02 Million USD | -8864.406% |
| Homology Medicines, Inc. | -48.25 Million USD | -29070.034% |
| Geron Corporation | -193.94 Million USD | -7157.765% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -4888.394% |
| Exelixis, Inc. | 170.88 Million USD | 8337.119% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -13860.546% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -25145.713% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -2631.66% |
| Zoetis Inc. | 3.06 Billion USD | 558.651% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -5971.821% |
| Abeona Therapeutics Inc. | -48.2 Million USD | -29103.32% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 426.779% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | -35851.268% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -3879.306% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 13220.561% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 4269.752% |
| Blueprint Medicines Corporation | -486.27 Million USD | -2794.646% |
| Insmed Incorporated | -709.62 Million USD | -1883.58% |
| TG Therapeutics, Inc. | 20.63 Million USD | 68320.811% |
| Incyte Corporation | 620.52 Million USD | 2368.402% |
| Emergent BioSolutions Inc. | -726.4 Million USD | -1837.775% |